Concepedia
1
Publications
84
Citations
H-Index
2023
Active since
Affiliations
Loxo Oncology at Lilly (United States)(Current)
Hetal S Randeria is an author at Loxo Oncology at Lilly (United States).
Publications per year
2023–2023
Pirtobrutinib preclinical characterization: a highly selective, non-covalent (reversible) BTK inhibitor
Eliana B Gómez, Kevin Ebata, Hetal S Randeria et al. · Blood · 2023 · 84 citations · Full text
Rows per page
1–1 of 1